Evotec publishes DDup 11 – AI-driven antibody discovery at Evotec


The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec’s “Multi-modality Autobahn.” 

For the biologics industry, Evotec provides a fast lane to drug discovery and development solutions. No matter where the project lies on the idea-to-IND continuum and beyond, Evotec’s experience supports all activities from target identification through to IND submission, with high-end manufacturing completing this one-stop-shop.

This comprehensive offering enables our partners to work with one experienced team for  more efficient, productive, faster, and flexible biologics drug discovery, development and manufacturing.